Marpai, Inc. (NASDAQ:MRAI – Get Free Report) was the target of a large decrease in short interest in April. As of April 15th, there was short interest totalling 116,600 shares, a decrease of 42.0% from the March 31st total of 201,100 shares. Based on an average trading volume of 453,500 shares, the days-to-cover ratio is currently 0.3 days. Currently, 2.3% of the company’s stock are short sold.
Marpai Trading Down 0.9 %
MRAI stock traded down $0.02 during trading on Friday, reaching $2.11. The company’s stock had a trading volume of 28,862 shares, compared to its average volume of 694,274. Marpai has a 1 year low of $0.33 and a 1 year high of $3.46. The company’s fifty day moving average is $2.06 and its 200-day moving average is $1.54.
Marpai (NASDAQ:MRAI – Get Free Report) last released its quarterly earnings data on Tuesday, March 26th. The company reported ($0.65) EPS for the quarter. The business had revenue of $8.71 million for the quarter.
Insider Activity at Marpai
Wall Street Analysts Forecast Growth
Separately, Maxim Group upgraded Marpai from a “hold” rating to a “buy” rating and set a $6.00 price target for the company in a research note on Thursday, March 28th.
View Our Latest Stock Report on Marpai
Marpai Company Profile
Marpai, Inc, a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, bill review and cost containment services.
Featured Articles
- Five stocks we like better than Marpai
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is the Dogs of the Dow Strategy? Overview and Examples
- How to Use Put Debit Spreads to Profit From Falling Stocks
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Marpai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marpai and related companies with MarketBeat.com's FREE daily email newsletter.